Gian Ussia

Showing 1-14 of 14 articles

Severe calcified paravalvular leak: usefulness of intravascular lithotripsy technology

Ricottini E, Carpenito M, Mega S, Ussia G

November 20, 2020 | 10.4244/EIJ-D-20-00392

Coronary interventions

Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a contemporary reappraisal

Pelliccia F, Niccoli G, Gragnano F, Limongelli G, Moscarella E, Andò G, Esposito A, Stabile E, Ussia G, Tarantini G, Gimeno JR, Elliott P, Calabrò P

August 29, 2019 | 10.4244/EIJ-D-18-00959

Interventions for valvular disease

Gender in the ACCESS-EU registry: a prospective, multicentre, non-randomised post-market approval study of MitraClip® therapy in Europe

Gafoor S, Sievert H, Maisano F, Baldus S, Schäfer U, Hausleiter J, Butter C, Ussia G, Geist V, Widder J, Moccetti T, Schillinger W, Franzen O

June 10, 2016 | 10.4244/EIJV12I2A40

Interventions for valvular disease

The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes

Gilard M, Schlüter M, Snow T, Dall’Ara G, Eltchaninoff H, Moat N, Goicolea J, Ussia G, Kala P, Wenaweser P, Zembala M, Nickenig G, Price S, Barrero E, Iung B, Zamorano P, Schuler G, Corti R, Alfieri O, Prendergast B, Ludman P, Windecker S, Sabaté M, Witkowski A, Danenberg H, Schroeder E, Romeo F, Macaya C, Derumeaux G, Laroche C, Pighi M, Serdoz R, Di Mario C

May 16, 2016 | 10.4244/EIJV12I1A15

Interventions for valvular disease

Percutaneous transfemoral-transseptal implantation of a second-generation CardiAQ™ mitral valve bioprosthesis: first procedure description and 30-day follow-up

Ussia G, Quadri A, Cammalleri V, De Vico P, Muscoli S, Marchei M, Ruvolo G, Søndergaard L, Romeo F

February 19, 2016 | 10.4244/EIJY15M09_01

Interventions for valvular disease

The CardiAQ transcatheter mitral valve implantation system

Søndergaard L, Ussia G, Dumonteil N, Quadri A

September 17, 2015 | 10.4244/EIJV11SWA22

Clinical results with the 31 mm CoreValve™ in large aortic annuli: the importance of implantation technique

Ussia G, Sarkar K, Cammalleri V, Marchei M, Muscoli S, De Vico P, Rubino D, De Persis F, Macrini M, Romeo F

January 22, 2015 | 10.4244/EIJV10I9A182

CoreValve implantation for severe aortic regurgitation: a multicentre registry

Testa L, Latib A, Rossi M, De Marco F, De Carlo M, Fiorina C, Oreglia J, Petronio A, Ettori F, De Servi S, Klugmann S, Ussia G, Tamburino C, Panisi P, Brambilla N, Colombo A, Presbitero P, Bedogni F

October 20, 2014 | 10.4244/EIJV10I6A127

Gender differences in patients undergoing TAVI: a multicentre study

D’ascenzo F, Gonella A, Moretti C, Omedè P, Salizzoni S, La Torre M, Giordana F, Barbanti M, Ussia G, Brambilla N, Bedogni F, Gaita F, Tamburino C, Sheiban I

July 26, 2013 | 10.4244/EIJV9I3A59

The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients

Di Mario C, Eltchaninoff H, Moat N, Goicolea J, Ussia G, Kala P, Wenaweser P, Zembala M, Nickenig G, Barrero E, Snow T, Iung B, Zamorano P, Schuler G, Corti R, Alfieri O, Prendergast B, Ludman P, Windecker S, Sabaté M, Gilard M, Witkowski A, Danenberg H, Schröder E, Romeo F, Macaya C, Derumeaux G, Maggioni A, Tavazzi L

April 19, 2013 | 10.4244/EIJV8I12A209

Transcatheter aortic bioprosthesis dislocation: technical aspects and midterm follow-up

Ussia G, Barbanti M, Sarkar K, Aruta P, Scarabelli M, Cammalleri V, Imme S, Pistritto A, Gulino S, Mulè M, Deste W, Cannata S, Tamburino C

March 21, 2012 | 10.4244/EIJV7I11A203

Safety and effectiveness of the Catania Polyzene-F coated stent in real world clinical practice: 12-month results from the ATLANTA 2 registry

Tamburino C, Capodanno D, Di Salvo M-E, Sanfilippo A, Cascone I, Incardona V, Longo G, Giacoppo D, Capranzano P, Sgroi C, Ussia G, Monaco A, La Manna A

January 20, 2012 | 10.4244/EIJV7I9A169

Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis

Ussia G, Barbanti M, Cammalleri V, Scarabelli M, Mulè M, Aruta P, Pistritto A, Imme S, Capodanno D, Sarkar K, Gulino S, Tamburino C

September 30, 2011 | 10.4244/EIJV7I5A93

Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving System: results from the multicentre, expanded evaluation registry 1-year following CE mark approval

Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde J-C, de Jaegere P, Serruys P

August 20, 2008

Latest news

NEW ISSUE

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

AHEAD OF PRINT

TAVI in younger (<70 years old) patients: the AMTRAC registry

Guy Witberg et al.

October 22, 2021

AHEAD OF PRINT

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hironori Hara et al.

October 22, 2021

AHEAD OF PRINT

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.